CATS - Catasys, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
13.16
-0.43 (-3.16%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close13.59
Open13.38
Bid10.02 x 800
Ask13.00 x 1000
Day's Range12.00 - 13.61
52 Week Range4.21 - 15.01
Volume157,721
Avg. Volume112,454
Market Cap212.996M
Beta (3Y Monthly)2.52
PE Ratio (TTM)N/A
EPS (TTM)-0.89
Earnings DateMar 5, 2019 - Mar 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.25
Trade prices are not sourced from all markets
  • GuruFocus.com2 days ago

    Catasys Inc (CATS) Files 10-K for the Fiscal Year Ended on December 31, 2018

    Catasys Inc is a healthcare services company, provides health services designed to assist health plans & employees to manage & treat their high cost substance dependence members through a network of healthcare providers & its employees. Catasys Inc had annual average EBITDA growth of 56.10% over the past ten years. Warning! GuruFocus has detected 5 Warning Signs with CATS.

  • Business Wire10 days ago

    Catasys Reports 2018 Fourth Quarter and Year-end Financial Results

    LOS ANGELES-- -- Q4 2018 Record Revenue of $5.6 Million, up 85.3% Year over Year and Up 28.7% from Q3 2018 YE 2018 Record Revenue of $15.2 Million, Up 96.7% from YE 2017 Outreach Pool of Eligible Members Increased to approximately 75,000 Members at March 1, 2019 as a Result of Significant Expansion within Existing Plans Reiterates 2019 GAAP Revenue Guidance of $35 Million Company to Host Conference ...

  • Business Wire10 days ago

    Catasys Announces Expansion of Debt Financing Agreement to $15 Million; Proceeds to be Utilized to Support Accelerating Growth

    Catasys, Inc. (CATS), a leading AI and technology-enabled healthcare company, announced today that it has entered into an amendment and expansion of its previously announced financing of a receivable facility agreement and term loan (see: Catasys Attracts $10 Million in Debt Financing to Support Accelerating Growth - June 14, 2018). The Company entered into a $15 million financing with Horizon Technology Finance Corporation (“Horizon”) (HRZN), which includes initial term loans in the amount of $7.5 million previously funded under the original Loan Agreement entered into June 2018 and an additional up to $7.5 million loan in three revolving tranches of $2.5 million. The initial interest rate on the term loan is 9.75% and will float with Libor when north of 2% (currently 2.49%).

  • Business Wire11 days ago

    Catasys to Present at Upcoming Investor Conferences

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to participate in two upcoming investor conferences in March, including the 31st Annual ROTH Conference in Laguna Niguel, California and the Oppenheimer 29th Annual Healthcare Conference in New York City.

  • Business Wire12 days ago

    Catasys Schedules Fourth Quarter 2018 Results Conference Call for March 14, 2019

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its fourth quarter and year ended December 31, 2018, after the closing of the stock market on Thursday, March 14, 2019.

  • Our Take On Catasys, Inc.’s (NASDAQ:CATS) CEO Salary
    Simply Wall St.16 days ago

    Our Take On Catasys, Inc.’s (NASDAQ:CATS) CEO Salary

    Terren Peizer has been the CEO of Catasys, Inc. (NASDAQ:CATS) since 2003. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth thatRead More...

  • GlobeNewswire26 days ago

    Sharps Compliance Adds Sharon R. Gabrielson, Chair of Mayo Clinic’s Global Business Solutions, to Board of Directors

    Sharps Compliance Corp. (SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today announced the appointment of Sharon R. Gabrielson to its Board of Directors. Ms. Gabrielson is a progressive healthcare executive with over 30 years of broad-based leadership experience in the healthcare industry.  She currently serves as Chair of Global Business Solutions for the Mayo Clinic, where she is responsible for directing domestic and international business development opportunities for the Clinic’s healthcare products and services to the B2B and B2C markets.  Previously, Ms. Gabrielson was Vice Chair of Mayo’s Health System Administration, where she oversaw an organization of community-based practices including hospitals, clinics, nursing homes, and home health, which generated approximately $2 billion in revenues.

  • Could Catasys, Inc.’s (NASDAQ:CATS) Investor Composition Influence The Stock Price?
    Simply Wall St.2 months ago

    Could Catasys, Inc.’s (NASDAQ:CATS) Investor Composition Influence The Stock Price?

    If you want to know who really controls Catasys, Inc. (NASDAQ:CATS), then you'll have to look at the makeup of its share registry. Institutions often own shares in more established Read More...

  • Weekly Jobless Claims Lowest Since November 1969: 5 Picks
    Zacks2 months ago

    Weekly Jobless Claims Lowest Since November 1969: 5 Picks

    The U.S. labor market is a picture of health at the moment fueled by strong job additions and record-low unemployment.

  • MoneyShow2 months ago

    Top Picks 2019- Catasys CATS

    For more speculative investors, one of my favorite stocks in our newsletter portfolio as 2019 gets underway is Catasys (CATS), explains Nate Pile, a growth stocks expert editor of Nate's Notes.

  • Will Catasys (CATS) Continue to Surge Higher?
    Zacks4 months ago

    Will Catasys (CATS) Continue to Surge Higher?

    As of late, it has definitely been a great time to be an investor in Catasys, Inc. (CATS).

  • Business Wire4 months ago

    Catasys Reports 2018 Third Quarter Financial Results

    LOS ANGELES-- -- Q3 2018 Record Billings of $6.3 Million, Up 210% Year over Year and Up 21% from Q2 Q3 2018 Record GAAP Revenue of $4.4 Million, Up 266% Year over Year and up 33% from Q2 Reiterates 2018 Billings Guidance of $20.0 Million Company Issues 2019 GAAP Revenue Guidance of $35 Million Company to Host Conference Call at 4:30 pm ET Today Catasys, Inc. , a leading AI and technology-enabled healthcare ...

  • Business Wire4 months ago

    Catasys to Announce Third Quarter 2018 Results and Host Conference Call on November 14, 2018

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its third quarter and nine months ended September 30, 2018, after the closing of the stock market on Wednesday, November 14, 2018.

  • Analysts Estimate Catasys (CATS) to Report a Decline in Earnings: What to Look Out for
    Zacks5 months ago

    Analysts Estimate Catasys (CATS) to Report a Decline in Earnings: What to Look Out for

    Catasys (CATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire5 months ago

    Catasys Appoints Three Healthcare Executives to Board of Directors

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Edward Zecchini, Sharon Gabrielson, and Diane Seloff to its Board of Directors. Rick Anderson and Dave Smith have stepped down as directors to accommodate the new Board members. With these changes, Catasys has a total of seven Board members.

  • Business Wire5 months ago

    Catasys Announces Signing of Agreement with Capital BlueCross

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that it has entered into an agreement with Capital BlueCross, a community-based health insurer serving members in 21 counties in Central Pennsylvania and the Lehigh Valley.

  • Catasys Sees Hammer Chart Pattern: Time to Buy?
    Zacks5 months ago

    Catasys Sees Hammer Chart Pattern: Time to Buy?

    Catasys has been struggling lately, but the selling pressure may be coming to an end soon.

  • Catasys Chief Medical Officer to Present Keynote Address at the 2018 Zarrow Mental Health Symposium: Innovations in Mental Health
    Business Wire6 months ago

    Catasys Chief Medical Officer to Present Keynote Address at the 2018 Zarrow Mental Health Symposium: Innovations in Mental Health

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that its Chief Medical Officer Dr. Omar Manejwala is expected to deliver a keynote address at the 2018 Zarrow Mental Health Symposium.

  • Business Wire6 months ago

    Catasys Calls for Improved Engagement to Solve for the Crisis of Untreated Anxiety Disorders in Published Paper Authored by Chief Medical Officer

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that a paper authored by its Senior Vice President and Chief Medical Officer Omar S.

  • Business Wire6 months ago

    Catasys Announces Expansion of OnTrak-A Solution to Florida and Georgia with Leading National Health Plan

    National Plan Expands OnTrak-A into 12th and 13th States

  • Catasys Expands OnTrak-A Solution to Iowa and Nebraska with Leading National Health Plan
    Business Wire6 months ago

    Catasys Expands OnTrak-A Solution to Iowa and Nebraska with Leading National Health Plan

    LOS ANGELES-- -- National Plan Expands OnTrak-A into 10 th and 11 th States OnTrak-A Offered to Both Commercial and Medicare Advantage Plan Members With This Launch, OnTrak Is Now Available in 22 States Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that it has expanded its OnTrak-A solution into Iowa and Nebraska with one of the nation’s leading health plans, ...

  • Business Wire7 months ago

    Catasys Reports 2018 Second Quarter Financial Results

    LOS ANGELES-- -- Q2 2018 Record Billings of $5.2 Million, Up 152% Year over Year Achieved a Record $2.4 Million in Billings in July 2018, Without Any Special Items Enrolled 1,219 New Members in Q2 2018, Up 289% Year over Year Secured Up to $10 Million in Debt Financing to Support Company’s Accelerating Growth Company Reiterates 2018 Billings Guidance of $20.0 Million Outreach Pool Is Now Approximately ...

  • Business Wire7 months ago

    Catasys to Announce Second Quarter 2018 Results and Host Conference Call on August 14, 2018

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its second quarter and six months ended June 30, 2018, after the closing of the stock market on Tuesday, August 14, 2018.

  • Business Wire8 months ago

    CORRECTING and REPLACING Catasys to Present at the Canaccord Genuity 38th Annual Growth Conference

    Headline of release dated August 1, 2018, should read: Catasys to Present at the Canaccord Genuity 38th Annual Growth Conference .